文献速递主动脉疾病血液透析通路

EVAR入路并发症的长期影响:VQI大样本分析

The long-term implications of access complications during endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2020-09-01

基于VQI 2011–2018年33,951例完整腹主动脉瘤EVAR,4.6%发生至少一种入路并发症,女性发生率近男性两倍(7.5% vs 3.9%)。入路并发症与围术期死亡(OR 4.2)及长期死亡风险升高(HR 1.6)独立相关。倾向加权分析显示女性经皮入路并发症 odds 更低(OR 0.6)。

要点

  • EVAR入路并发症总体发生率4.6%,女性显著高于男性(7.5% vs 3.9%)。
  • 入路并发症使围术期死亡 odds 升高4.2倍,长期死亡风险升高60%。
  • 女性经皮入路并发症 odds 显著低于切开(OR 0.6)。

核心结论

  • 当前EVAR入路并发症虽不常见,但与围术期及长期死亡率和并发症显著相关。
  • 女性是入路并发症的高危因素,但可能从经皮入路中获益。

研究设计与样本

  • 回顾性队列研究,使用Vascular Quality Initiative 2011–2018年数据。
  • 纳入33,951例无既往主动脉手术的完整腹主动脉瘤EVAR(91%择期,9%有症状)。
  • 采用多水平logistic回归和倾向加权分析,缺失数据用多重插补。

主要发现

  • 1,553例(4.6%)发生至少一种入路并发症(血栓、栓塞、伤口感染、血肿、中转切开)。
  • 女性入路并发症发生率7.5%,男性3.9%(P < .001)。
  • 经皮中转切开者并发症率8.6%,高于计划切开者2.9%(P < .001)。
  • 入路并发症患者围术期死亡OR 4.2(95%CI 2.5-7.1,P < .001),长期死亡HR 1.6(95%CI 1.2-2.1,P = .001)。
  • 入路并发症患者再手术率19% vs 1.2%、心梗3.5% vs 0.7%、卒中0.8% vs 0.2%、急性肾损伤12% vs 3%、再插管5.7% vs 0.8%(均P < .001)。

关键数值与推荐

  • 入路并发症相关因素:女性(OR 2.7,95%CI 2.0-3.6,P < .001)、年龄每增5岁(OR 1.05,95%CI 1.02-1.1,P < .01)。
  • 主髂单侧装置(OR 1.6,95%CI 1.1-2.3,P < .01)、吸烟(OR 1.4,95%CI 1.1-1.7,P < .01)。
  • BMI低于16(OR 1.8,95%CI 1.3-2.5,P = .001)、双联抗血小板(OR 1.3,95%CI 1.02-1.6,P = .03)。
  • 既往腹股沟下旁路(OR 1.8,95%CI 1.3-2.7,P < .01)、β受体阻滞剂(OR 1.2,95%CI 1.03-1.4,P = .02)。
  • 倾向加权分析中,女性经皮入路并发症OR 0.6(95%CI 0.4-0.96,P = .03)。

临床怎么用

  • EVAR术前应评估入路并发症风险,尤其女性、高龄、低BMI、吸烟及双联抗血小板患者。
  • 对女性患者可优先考虑经皮入路以降低入路并发症 odds。
  • 发生入路并发症后需警惕围术期死亡及长期死亡风险升高,加强术后监测。

局限性

  • 原文摘要未报告回顾性登记研究的其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Access issues are one of the most common complications of endovascular aneurysm repair (EVAR). However, contemporary rates as well as risk factors for complications and the subsequent impact of access complications on mortality are poorly described. METHODS: We studied all EVAR for intact abdominal aortic aneurysms without prior aortic surgery in the Vascular Quality Initiative between 2011 and 2018. We studied factors associated with access complications (thrombosis, embolus, wound infection, hematoma, and conversion to cutdown), as well as the interaction with female sex and the impact on survival using multilevel logistic regression and propensity weighting. Multiple imputation was used for missing data. RESULTS: There were 33,951 EVAR during the study period (91% elective, 9% symptomatic); most cases (70%) involved an attempt at percutaneous access on at least one side, with 30% bilateral cutdowns and 0.1% iliac conduits. There were 1553 patients (4.6%) who experienced at least one access complication. Access complications were almost twice as common in female patients (7.5% vs 3.9%; P < .001). The factors associated with access complications included female sex (odds ratio [OR], 2.7; 95% confidence interval [CI], 2.0-3.6; P < .001), age (OR, 1.05 per 5 years; 95% CI, 1.02-1.1; P < .01), aortouni-iliac device (OR, 1.6; 95% CI, 1.1-2.3; P < .01), smoking (OR, 1.4; 95% CI, 1.1-1.7; P < .01), body mass index of less than 16 (OR, 1.8; 95% CI, 1.3-2.5; P = .001), dual antiplatelet therapy (1.3; 95% CI, 1.02-1.6 P = .03), prior infrainguinal bypass (OR, 1.8; 95% CI, 1.3-2.7; P < .01), and beta blocker use (OR, 1.2; 95% CI, 1.03-1.4; P = .02). Conversion from percutaneous access to open cutdown was associated with higher rates of complications than planned open cutdown (8.6% vs 2.9%; P < .001). In propensity-weighted analysis, percutaneous access was associated with significantly lower odds of access complications in women (OR, 0.6; 95% CI, 0.4-0.96; P = .03). Patients who experienced an access complication had more than four times the odds of perioperative death (OR, 4.2; 95% CI, 2.5-7.1; P < .001), and a 60% higher risk of long-term mortality (hazard ratio, 1.6; 95% CI, 1.2-2.1; P = .001). In addition to death, patients with access site complications had higher rates of other major complications, including reoperation during the index hospitalization (19% vs 1.2%; P < .001), myocardial infarction (3.5% vs 0.7%; P < .001), stroke (0.8% vs 0.2%; P < .001), acute kidney injury (12% vs 3%; P < .001), and reintubation (5.7% vs 0.8%). CONCLUSIONS: Although access complications are infrequent in the current era, they are associated with both perioperative and long-term morbidity and mortality. Female patients in particular are at high risk of access complications, but may benefit from percutaneous access.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. O'Donnell TFX, Deery SE, Boitano LT, et al. The long-term implications of access complications during endovascular aneurysm repair. J Vasc Surg. 2020. PMID: 32889076. doi:10.1016/j.jvs.2020.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。